Company intelligence / Profile preview

KARDI AI Technologies

Olomouc, Olomouc, Czech Republic

Ownership: Private
Development stage: Other

Overview

Kardi Ai's wearable, AI-driven ECG solution is CE certified as a Class IIa medical device (EU MDR), demonstrates 6x higher arrhythmia detection rates vs. 24-hr holter, detects arrhythmias in 23-29% of users, and has been used by over 2,300 patients.

Therapeutic areas: Cardiovascular
Modalities: DeviceNon-pharmacological therapy
Industry: Physiological Monitoring

Partnerships

Soulmates VenturesPurple VenturesBrightCap VenturesDepo VenturesGarage AngelsCleverage

Beyond the preview

Go deeper on KARDI AI Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KARDI AI Technologies.

Explore the full profile